Valuation: Telix Pharmaceuticals Limited

Market Cap 6.07B 4.32B 3.76B 3.55B 3.22B 6.03B 414B 42.45B 16.4B 211B 16.21B 15.85B 677B P/E 2026 *
233x
P/E 2027 * 773x
Enterprise Value 6.5B 4.62B 4.03B 3.8B 3.45B 6.46B 443B 45.47B 17.57B 226B 17.36B 16.98B 725B EV / Sales 2026 *
4.73x
EV / Sales 2027 * 4.19x
Free-Float
83.13%
Yield 2026 *
-
Yield 2027 * -
1 day+2.29%
1 week+6.50%
Current month+16.21%
1 month+8.51%
3 months+26.15%
6 months+52.56%
Current year+59.38%
1 week 15.85
Extreme 15.85
18.22
1 month 14.86
Extreme 14.86
18.22
Current year 8.26
Extreme 8.26
18.22
1 year 8.26
Extreme 8.26
18.32
3 years 8.2
Extreme 8.2
31.97
5 years 3.55
Extreme 3.55
31.97
10 years 0.46
Extreme 0.46
31.97
Manager TitleAgeSince
Chief Executive Officer 51 02/01/2017
Director of Finance/CFO 61 30/07/2022
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 51 02/01/2017
Chairman 66 02/02/2026
Director/Board Member 68 18/06/2018
Date Insider Type Main position Quantity % Market Cap. Importance
07/09/26 Buy

Chief Financial Officer

2,071 0.0006%
26/05/26 Free

Director

21,597 0.0064%
26/05/26 Free

Founder

339,845 0.1001%
Change 5-day change 1-year change 3-year change Capi.($)
+2.29%+6.50%+28.23%+53.61% 4.22B
+0.11%+1.98%-0.04%+9.69% 46.18B
-1.12%+3.54%+42.71%+25.84% 44.35B
-3.04%-6.10%+335.86%+501.23% 42.21B
-0.74%+2.64%+5.61%+75.14% 40.19B
-0.50%-0.77%+11.86%+40.41% 29.83B
-0.46%+5.00%+23.00%+118.70% 17.17B
-0.97%-9.38% - - 15.7B
-0.57%+7.78%+21.76%+38.08% 15.32B
-3.28%-0.95%-6.34%-37.29% 13.09B
Average -0.83%+1.91%+51.41%+91.71% 26.83B
Weighted average by Cap. -1.05%+1.67%+68.95%+116.16%

Financials

2026 *2027 *
Net sales 1.37B 977M 851M 803M 729M 1.37B 93.64B 9.61B 3.71B 47.67B 3.67B 3.59B 153B 1.56B 1.11B 970M 915M 831M 1.56B 107B 10.95B 4.23B 54.35B 4.18B 4.09B 175B
Net income 27.78M 19.77M 17.22M 16.25M 14.75M 27.64M 1.9B 194M 75.13M 965M 74.25M 72.62M 3.1B 1.14M 813K 708K 668K 607K 1.14M 77.95M 8M 3.09M 39.68M 3.05M 2.99M 128M
Net Debt 431M 307M 267M 252M 229M 429M 29.41B 3.02B 1.17B 14.97B 1.15B 1.13B 48.15B 491M 349M 304M 287M 260M 488M 33.47B 3.43B 1.33B 17.04B 1.31B 1.28B 54.78B
Logo Telix Pharmaceuticals Limited
Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.
Employees
1,152
Date Price Change Volume
18/09/26 A$17.85 +2.29% 3,062,365
17/09/26 A$17.45 +3.44% 2,277,535
16/09/26 A$16.87 -4.96% 3,613,622
15/09/26 A$17.75 +8.63% 6,277,577
14/09/26 A$16.34 +4.28% 4,723,800
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
17.85AUD
Average target price
23.52AUD
Spread / Average Target
+31.78%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!